tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ELTX Stock Latest News

Elicio Therapeutics price target lowered to $10 from $11 at H.C. Wainwright
The FlyElicio Therapeutics price target lowered to $10 from $11 at H.C. Wainwright
8d ago
ELTX
Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing AMPLIFY-201 Phase 1 Study of ELI-002 and Preclinical Data on ELI-007 and ELI-008 at the AACR Annual Meeting
PremiumPress Releases
Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing AMPLIFY-201 Phase 1 Study of ELI-002 and Preclinical Data on ELI-007 and ELI-008 at the AACR Annual Meeting
1M ago
ELTX
Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates
PremiumPress Releases
Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates
1M ago
ELTX
Elicio Therapeutics to sell 1.03M shares $5.81 in private placement financing
PremiumThe Fly
Elicio Therapeutics to sell 1.03M shares $5.81 in private placement financing
2M ago
ELTX
Elicio Therapeutics Announces $6.0 Million Private Placement Financing
PremiumPress Releases
Elicio Therapeutics Announces $6.0 Million Private Placement Financing
2M ago
ELTX
Elicio Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting
PremiumPress ReleasesElicio Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting
2M ago
ELTX
Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PremiumPress Releases
Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
3M ago
ELTX
Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating TCR-T Cell Therapy in Combination with Lymph Node-Targeted Amphiphile-Immunotherapy Enhanced Anti-Tumor Function and Eradicated Solid Tumors
PremiumPress Releases
Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating TCR-T Cell Therapy in Combination with Lymph Node-Targeted Amphiphile-Immunotherapy Enhanced Anti-Tumor Function and Eradicated Solid Tumors
4M ago
ELTX
Elicio Therapeutics announces preclinical data on TCR-T therapy
PremiumThe Fly
Elicio Therapeutics announces preclinical data on TCR-T therapy
4M ago
ELTX
Elicio Therapeutics to present ELI-002 trial in progress poster
PremiumThe Fly
Elicio Therapeutics to present ELI-002 trial in progress poster
4M ago
ELTX
Elicio Therapeutics to Present ELI-002 7P (AMPLIFY-7P) Trial in Progress Poster on Phase 1/2 Study of Lymph Node-Targeted Vaccine at ASCO GI Symposium
PremiumPress Releases
Elicio Therapeutics to Present ELI-002 7P (AMPLIFY-7P) Trial in Progress Poster on Phase 1/2 Study of Lymph Node-Targeted Vaccine at ASCO GI Symposium
4M ago
ELTX
Elicio Therapeutics price target raised to $11 from $10 at H.C. Wainwright
PremiumThe Fly
Elicio Therapeutics price target raised to $11 from $10 at H.C. Wainwright
4M ago
ELTX
Elicio Therapeutics to Present at the B. Riley Securities 4th Annual Oncology Conference
PremiumPress ReleasesElicio Therapeutics to Present at the B. Riley Securities 4th Annual Oncology Conference
4M ago
ELTX
Elicio announces first patient dosed in Phase 2 study of ELI-002
PremiumThe Fly
Elicio announces first patient dosed in Phase 2 study of ELI-002
4M ago
ELTX
Elicio Therapeutics Announces First Patient Dosed in Randomized Phase 2 Pancreatic Cancer Study
PremiumPress Releases
Elicio Therapeutics Announces First Patient Dosed in Randomized Phase 2 Pancreatic Cancer Study
4M ago
ELTX
Angion Biomedica Corp trading resumes
PremiumThe Fly
Angion Biomedica Corp trading resumes
4M ago
ELTX
Angion Biomedica Corp trading halted, volatility trading pause
PremiumThe Fly
Angion Biomedica Corp trading halted, volatility trading pause
4M ago
ELTX
Elicio Therapeutics’ ELI-002 shows antitumor efficacy in published Phase 1 trial
PremiumThe Fly
Elicio Therapeutics’ ELI-002 shows antitumor efficacy in published Phase 1 trial
4M ago
ELTX
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
PremiumPress Releases
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
4M ago
ELTX
Angion Biomedica Corp trading resumes
PremiumThe FlyAngion Biomedica Corp trading resumes
4M ago
ELTX
Angion Biomedica Corp trading halted, volatility trading pause
PremiumThe Fly
Angion Biomedica Corp trading halted, volatility trading pause
4M ago
ELTX
Angion Biomedica Corp trading resumes
PremiumThe Fly
Angion Biomedica Corp trading resumes
4M ago
ELTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >